Corylin inhibits the progression of Non-small cell lung cancer cells by regulating NF-κB signaling pathway via targeting p65

Background: Lung cancer is characterized by high-risk and high mortality, among which non-small cell lung cancer (NSCLC) conquers a dominant position. Previous studies have reported that corylin has antiinflammatory, anti-oxidant, and anti-tumor effects; however, its role in NSCLC cells remains unclear. Hypothesis: Corylin inhibits the progression of NSCLC cells. Methods: A lentivector NF-kappa B luciferase reporter was constructed by molecular cloning. Corylin was screened and identified as an NF-kappa B pathway inhibitor by luciferase reporter assay. Corylin inhibited the expression of NF-kappa B downstream genes, which was detected by qRT-PCR. The effect of corylin on NSCLC cells was detected by colony formation assay, cell apoptosis, cell proliferation, in vitro invasion, and cell scratch assay. Corylin inhibited p65 nuclear translocation and was detected by molecular docking, immunofluorescence assay, and Western blot analysis. Results: We constructed a lentiviral expression vector, containing an NF-kappa B luciferase reporter and established a stable A549 cell line for its expression. Using this cell line, corylin was screened and identified as an NF-kappa B pathway inhibitor. It was found that corylin inhibited the expression of NF-kappa B downstream genes and inhibited the proliferation and migration of NSCLC cells. Meanwhile, it was also found that corylin significantly reversed the increased proliferation of NSCLC cell lines induced by p65 overexpression. Molecular docking analysis showed that corylin could bind to p65 by hydrogen bonding. Further study showed that corylin inhibited the NF-kappa B signaling pathway by blocking p65 nuclear translocation. Conclusions: Our study screened and identified corylin as an NF-kappa B inhibitor and elucidated the molecular mechanism by which corylin inhibits the growth of NSCLC cells. The present study provides a novel strategy for improving the prognosis and treatment of NSCLC patients.

Automated summary

The study found that corylin is a substance that inhibits the progression of non-small cell lung cancer cells, and it inhibits the NF-kappa B signaling pathway by blocking p65 nuclear translocation. The study provides a novel strategy for improving the prognosis and treatment of non-small cell lung cancer patients.